A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

Peer Review reports

Original Submission
5 Mar 2018	Submitted	Original manuscript
9 May 2018	Author responded	Author comments - Johannes Betge
Resubmission - Version 2
9 May 2018	Submitted	Manuscript version 2
Publishing
10 Jul 2018	Editorially accepted
18 Jul 2018	Article published	10.1186/s12885-018-4665-2

Back to article page